Design of O-acetylserine sulfhydrylase inhibitors by mimicking nature.

Journal of Medicinal Chemistry
Enea SalsiAndrea Mozzarelli

Abstract

The inhibition of cysteine biosynthesis in prokaryotes and protozoa has been proposed to be relevant for the development of antibiotics. Haemophilus influenzae O-acetylserine sulfhydrylase (OASS), catalyzing l-cysteine formation, is inhibited by the insertion of the C-terminal pentapeptide (MNLNI) of serine acetyltransferase into the active site. Four-hundred MNXXI pentapeptides were generated in silico, docked into OASS active site using GOLD, and scored with HINT. The terminal P5 Ile accounts for about 50% of the binding energy. Glu or Asp at position P4 and, to a lesser extent, at position P3 also significantly contribute to the binding interaction. The predicted affinity of 14 selected pentapeptides correlated well with the experimentally determined dissociation constants. The X-ray structure of three high affinity pentapeptide-OASS complexes were compared with the docked poses. These results, combined with a GRID analysis of the active site, allowed us to define a pharmacophoric scaffold for the design of peptidomimetic inhibitors.

References

Jan 1, 1983·Annual Review of Biochemistry·A J Cooper
Apr 4, 1997·Journal of Molecular Biology·G JonesR Taylor
Oct 8, 1998·Journal of Molecular Biology·P BurkhardJ N Jansonius
Aug 26, 2000·European Journal of Medicinal Chemistry·G Eugene Kellogg, D J Abraham
Sep 19, 2000·Bioscience, Biotechnology, and Biochemistry·K MinoK Nakanishi
Dec 5, 2000·Current Opinion in Biotechnology·L E Alksne, S J Projan
May 15, 2001·Journal of Computer-aided Molecular Design·G E KelloggD J Abraham
May 15, 2003·Angewandte Chemie·Michael R Barbachyn, Charles W Ford
Sep 4, 2003·The Journal of Experimental Medicine·Dirk SchnappingerGary K Schoolnik
May 6, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Brad SpellbergJohn E Edwards
Jul 3, 2004·The Journal of Biological Chemistry·Valerie E PyePeter C E Moody
Sep 1, 1994·Acta Crystallographica. Section D, Biological Crystallography·UNKNOWN Collaborative Computational Project, Number 4
May 1, 1997·Acta Crystallographica. Section D, Biological Crystallography·G N MurshudovE J Dodson
Aug 31, 2004·Acta Crystallographica. Section D, Biological Crystallography·Jason Gorman, Lawrence Shapiro
Nov 4, 2004·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·D M Livermore
Dec 2, 2004·Acta Crystallographica. Section D, Biological Crystallography·Paul Emsley, Kevin Cowtan
Jul 1, 2005·Protein Science : a Publication of the Protein Society·Barbara CampaniniAndrea Mozzarelli
Aug 18, 2005·Journal of the American Chemical Society·Kristin E BurnsTadhg P Begley
Oct 19, 2005·Advances in Parasitology·Tomoyoshi NozakiMasaharu Tokoro
Jan 31, 2006·Biochemical and Biophysical Research Communications·Chunhui ZhaoKazuhiro Nakanishi
Feb 24, 2006·International Journal of Clinical Practice·W V Kern
Jun 1, 2006·The Journal of Biological Chemistry·Gareth D WestropGraham H Coombs
Oct 27, 2006·FEMS Microbiology Reviews·Dorothea Kessler
Mar 10, 2007·European Journal of Medicinal Chemistry·Francesca SpyrakisPietro Cozzini
Aug 21, 2007·British Journal of Pharmacology·A R M Coates, Y Hu

❮ Previous
Next ❯

Citations

Sep 15, 2011·Chemical Reviews·Paola ContiCarlo De Micheli
Dec 20, 2011·The Journal of Biological Chemistry·Ting Wang, Thomas S Leyh
Oct 30, 2013·PloS One·Francesca SpyrakisAndrea Mozzarelli
Mar 21, 2013·Current Opinion in Structural Biology·Joseph M Jez, Sanghamitra Dey
May 10, 2011·Biochimica Et Biophysica Acta·Andrea MozzarelliPaul F Cook
Sep 3, 2013·The FEBS Journal·Marialaura MarchettiAndrea Mozzarelli
Dec 21, 2011·Journal of Enzyme Inhibition and Medicinal Chemistry·Ratna SinghAndrea Mozzarelli
Mar 4, 2015·Biochimica Et Biophysica Acta·Barbara CampaniniAndrea Mozzarelli
Oct 22, 2014·Amino Acids·Marialaura MarchettiAndrea Mozzarelli
Jul 6, 2016·Journal of Medicinal Chemistry·Katharina BrunnerGunter Schneider
Aug 18, 2016·Proceedings of the National Academy of Sciences of the United States of America·Parker M JohnsonCelia W Goulding
Sep 18, 2018·Journal of Enzyme Inhibition and Medicinal Chemistry·Joana MagalhãesBarbara Campanini
Sep 27, 2018·Journal of Enzyme Inhibition and Medicinal Chemistry·Nina FrankoAndrea Mozzarelli
Oct 12, 2018·Microbiology·Joanna L Hicks, Claire V Mullholland
Oct 27, 2018·Journal of Enzyme Inhibition and Medicinal Chemistry·Joana MagalhãesGabriele Costantino
May 15, 2018·Current Medicinal Chemistry·Xiao HuAlessandro Contini
Jun 1, 2013·Molecular Informatics·Agostino BrunoGabriele Costantino
Mar 13, 2014·ChemMedChem·Francesca SpyrakisAndrea Mozzarelli
Jul 4, 2012·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Paul K FyfeWilliam N Hunter
Nov 10, 2020·The Journal of Biological Chemistry·Abhishek KaushikS Kumaran
Feb 11, 2021·Journal of Bioscience and Bioengineering·Emi TakedaTakashi Nakamura
May 30, 2014·Journal of Agricultural and Food Chemistry·Luca DellafioraPietro Cozzini
Feb 27, 2018·Journal of Chemical Information and Modeling·Joana MagalhãesGabriele Costantino

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.